ResearchMoz

Browse reports in Therapeutic Area

Displaying 1 to 30 (of 810 records)
Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)
May 2014   |   By - Kelly Scientific Publications
GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis)” by Kelly Scientific Publications is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market...
$3400
HIV Therapeutics in Major Developed Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
Apr 2014   |   By - GBI Research
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market...
$3500
HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth
Apr 2014   |   By - GBI Research
The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market...
$3500
Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
Apr 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets...
$3500
Smoking Cessation Products - US - March 2014
Mar 2014   |   By - Mintel
E-cigarettes are the latest threat to the beleaguered smoking cessation products’ market. Prior to the rapid arrival and use of e-cigarettes, the fast-following introduction by private label manufacturers of every new product innovation launched by national brands helped commoditize the market and erode dollar sales growth. Future innovation should focus on smaller, cheaper product...
$3996
Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns
Mar 2014   |   By - GBI Research
GBI Research has released its pharma research: ‘Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns ’, which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation...
$3500
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014
Mar 2014   |   By - La Merie Publishing
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014. Marketed...
$1523
PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding
Mar 2014   |   By - GlobalData
GlobalDatas "PharmaSphere: Emerging Biotech Investment Report Strategic Trends in Private Equity and Venture Capital Funding" report provides in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry, bearing in mind that these are expected to have significant impact on the future of emerging biotechnology...
$2995
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool
Mar 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘NSCLC Therapeutics in APAC Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool’, which provides in-depth insights into the Non-Small Cell Lung Cancer (NSCLC) indication. The report provides an estimation of the market...
$3500
Investigation Report on China Aripiprazole Market, 2009 - 2018
Mar 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Schizophrenia is a common mental disorder. Data shows that mental illness has exceeded cardiovascular system, respiratory diseases and malignant tumors and turns into the heaviest social burden. Statistics shows that by the end of 2013 there have been over 10 million schizophrenia patients in China, and the number is still increasing year after year.  Schizophrenia is a chronic...
$1800
Investigation Report on China Imatinib Market, 2009 - 2018
Mar 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China and 95% of chronic leukemia. CML patients vary from the very young to the very old, and the incidence increases as people grow old.  CML treatment went through a long period of development....
$1800
United States and Japan - Proton Therapy Market, Patients & Forecast
Mar 2014   |   By - Renub Research
Proton therapy has become a subject of considerable interest in the radiation oncology community and it is expected that there will be a substantial growth in proton treatment facilities during the next decade. Proton therapy, one of the most intriguing developments in cancer treatment, carries a price tag as intimidating as its size. At a cost of US$ 125 Million, and sometimes much more,...
$1475
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability
Mar 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Epilepsy Therapeutics to 2019 in Asia-Pacific Market’, which provides in-depth analysis of epilepsy market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market...
$3500
Investigation Report on China Quetiapine Market, 2009 - 2018
Feb 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can lead to recurrent or persistent symptoms in most patients' whole life. As Chinese economy and society develops, life and work here has become increasingly stressful. As a result, recurrence rate of schizophrenia has also increased. Statistics shows that the number of schizophrene in China has exceeded 10 million...
$1800
Investigation Report on China Pemetrexed Market, 2009 - 2018
Feb 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market.  Approved by FDA in February 2004, pemetrexed is to treat unresectable malignant pleural mesothelioma with cisplatin. It is the first drug approved by FDA to treat the disease. In August 2004 pemetrexed was approved...
$1800
Global and China Multifunctional low frequency therapeutic equipment Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Multifunctional low frequency therapeutic equipment basic information included Multifunctional low frequency therapeutic equipment definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence,...
$2200
Trino Therapeutics Ltd - Product Pipeline Review - 2014
Feb 2014   |   By - Global Markets Direct
Global Markets Direct’s, ‘Trino Therapeutics Ltd - Product Pipeline Review - 2014’, provides an overview of the Trino Therapeutics Ltd’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Trino Therapeutics Ltd’s, complete with comparative analysis at various...
$1500
Investigation Report on China Rituximab Market, 2009 - 2018
Feb 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Rituximab (trade names MabThera" by Roche, "Rituxan" by Genetech) is a chimeric monoclonal antibody against the protein CD20 approved in 1997 to treat tumor. It is very effective and shows good tolerance in the treatment of B-cell lymphoma. As people understand more about B-cell and its action mechanism, it is acknowledged that besides B-cell malignancies rituximab can also treat autoimmune...
$1800
Investigation Report on China Budesonide Market, 2009 - 2018
Feb 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Asthma and allergic rhinitis are both very common diseases in the world today. As the global atmosphere becomes more and more seriously contaminated, incidence of these diseases increases year by year.  Budesonide inhalation suspension (trade name "Pulmicort Respules") developed by Astra Zeneca was approved to market by FDA for asthma treatment in August 2000. It obtained import...
$1800
Investigation Report on China Duloxetine Market, 2009 - 2018
Feb 2014   |   By - China Research and Intelligence Co., Ltd. (CRI)
Depression is a common mood disorder that belongs to high-incidence mental diseases worldwide. Its main clinical features are a state of low mood and aversion to activity, and sometimes even suicidal thoughts or behaviors.  According to statistics from World Health Organization (WHO), depression is one of the most disabling diseases in the world today with over 0.3 billion...
$1800
Global and China Tumor Therapy Apparatus Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Tumor therapy apparatus basic information included Tumor therapy apparatus definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Tumor therapy apparatus industry policy and plan, Tumor therapy apparatus product...
$2200
PharmaSphere: Healthcare Information Technology Software and Services Report - Vertical Market Analysis of Leading IT Business Process Outsourcing and Electronic Medical Record Vendors
Feb 2014   |   By - GlobalData
PharmaSphere: Healthcare Information Technology Software and Services Report Vertical Market Analysis of Leading IT Business Process Outsourcing and Electronic Medical Record Vendors" report discusses the various platforms, service models, and go-to-market strategies of the major players in the IT BPO, and EMR markets. The research provides an assessment of vendor strategies, outsourcing...
$2995
Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth
Feb 2014   |   By - GBI Research
GBI Research has released its pharma report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment and Market Growth.” The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in...
$3500
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description
Feb 2014   |   By - GBI Research
GBI Research has released its pharma report “Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be...
$3500
Global Proton Therapy Market: Trends & Opportunities (2013-2018)
Feb 2014   |   By - Daedal Research
Executive Summary Proton therapy or proton beam therapy is a highly precise method of radiotherapy. The treatment is suitable for all patients regardless of age and as proton-therapy technology is continuously advancing, features such as rotational gantries, higher energies and larger fields have expanded the treatment's application to potentially any site in the body....
$800
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape
Jan 2014   |   By - GBI Research
GBI Research, has released the pharma report – “Hepatitis C Therapeutics in Major Developed Markets to 2019 – Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape”. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1...
$3500
PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 - 2012
Jan 2014   |   By - GlobalData
PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 2012 report provides an in-depth understanding of the key deals that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the...
$2995
Global and China Brainwave synchronization therapy device Industry 2014 Market Research Report
Jan 2014   |   By - QYResearch
The report firstly introduced Brainwave synchronization therapy device basic information included Brainwave synchronization therapy device definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Brainwave synchronization therapy device...
$2200
Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries
Jan 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, ‘Gastrointestinal Therapeutics (Irritable Bowel Syndrome, Ulcerative Colitis and Crohn’s Disease) in Major Developed Markets’, which provides insights into three gastrointestinal therapeutic indications in the major developed markets of the US, the UK, France, Germany, Italy,...
$3500
Global Radiation Therapy Market Report: 2013 Edition
Jan 2014   |   By - Koncept Analytics
Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination with surgery or chemotherapy. From conventional radiotherapy to advanced forms of treatment such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and proton therapy have become more...
$800
 
Displaying 1 to 30 (of 810 records)

Therapeutic Area Market Research Reports & Industry Analysis

A Therapeutic area typically refers to a particular category of condition or disease that has known medical treatments, drugs, or other promising drug discoveries in development. It is a method of classifying medical drugs without any reference to the form or type of therapy, or without taking a look at the disease it treats. 
For instance, cardiology could be included in the therapeutic area. Similarly, other categories such as dermatology, urology, psychotherapy, travel medicine, gynecological therapy could be classified as therapeutic areas too.  
The global therapy industry includes treatments intended to protect, cure, or manage specific diseases or illnesses in the body. Nonetheless, the treatment of every therapeutic area and its subsequent conditions vary widely and independently. 
Representing Internet’s leading research reports from industry experts and analysts, ResearchMoz is your go-to-source of information for therapeutic areas. All our reports are put together by our efficient team of analysts that use data and information sourced from leading primary and secondary contacts, corporate websites, investor presentations, and industry-specific third party sources across various therapy areas. We are here to cater you with the right research reports to fulfill your requirements and purchase budgets. Find the information you need on therapeutic area of pharmaceutical and healthcare markets on ResearchMoz.us.  

Therapeutic Area

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData